Colli Agostino, Gana Juan Cristóbal, Yap Jason, Adams-Webber Thomasin, Rashkovan Natalie, Ling Simon C, Casazza Giovanni
Department of Internal Medicine, A Manzoni Hospital ASST Lecco, Via dell'Eremo, 9/11, Lecco, Italy, 23900.
Gastroenterology and Nutrition Department, Division of Pediatrics, Escuela de Medicina, Pontificia Universidad Católica de Chile, 85 Lira, Santiago, Region Metropolitana, Chile, 8330074.
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD008759. doi: 10.1002/14651858.CD008759.pub2.
Current guidelines recommend screening of people with oesophageal varices via oesophago-gastro-duodenoscopy at the time of diagnosis of hepatic cirrhosis. This requires that people repeatedly undergo unpleasant invasive procedures with their attendant risks, although half of these people have no identifiable oesophageal varices 10 years after the initial diagnosis of cirrhosis. Platelet count, spleen length, and platelet count-to-spleen length ratio are non-invasive tests proposed as triage tests for the diagnosis of oesophageal varices.
Primary objectives To determine the diagnostic accuracy of platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices of any size in paediatric or adult patients with chronic liver disease or portal vein thrombosis, irrespective of aetiology. To investigate the accuracy of these non-invasive tests as triage or replacement of oesophago-gastro-duodenoscopy. Secondary objectives To compare the diagnostic accuracy of these same tests for the diagnosis of high-risk oesophageal varices in paediatric or adult patients with chronic liver disease or portal vein thrombosis, irrespective of aetiology.We aimed to perform pair-wise comparisons between the three index tests, while considering predefined cut-off values.We investigated sources of heterogeneity.
The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Hepato-Biliary Group Diagnostic Test Accuracy Studies Register, the Cochrane Library, MEDLINE (OvidSP), Embase (OvidSP), and Science Citation Index - Expanded (Web of Science) (14 June 2016). We applied no language or document-type restrictions.
Studies evaluating the diagnostic accuracy of platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices via oesophago-gastro-duodenoscopy as the reference standard in children or adults of any age with chronic liver disease or portal vein thrombosis, who did not have variceal bleeding.
Standard Cochrane methods as outlined in the Cochrane Handbook for Diagnostic Test of Accuracy Reviews.
We included 71 studies, 67 of which enrolled only adults and four only children. All included studies were cross-sectional and were undertaken at a tertiary care centre. Eight studies reported study results in abstracts or letters. We considered all but one of the included studies to be at high risk of bias. We had major concerns about defining the cut-off value for the three index tests; most included studies derived the best cut-off values a posteriori, thus overestimating accuracy; 16 studies were designed to validate the 909 (n/mm/mm cut-off value for platelet count-to-spleen length ratio. Enrolment of participants was not consecutive in six studies and was unclear in 31 studies. Thirty-four studies assessed enrolment consecutively. Eleven studies excluded some included participants from the analyses, and in only one study, the time interval between index tests and the reference standard was longer than three months. Diagnosis of varices of any size. Platelet count showed sensitivity of 0.71 (95% confidence interval (CI) 0.63 to 0.77) and specificity of 0.80 (95% CI 0.69 to 0.88) (cut-off value of around 150,000/mm from 140,000 to 150,000/mm; 10 studies, 2054 participants). When examining potential sources of heterogeneity, we found that of all predefined factors, only aetiology had a role: studies including participants with chronic hepatitis C reported different results when compared with studies including participants with mixed aetiologies (P = 0.036). Spleen length showed sensitivity of 0.85 (95% CI 0.75 to 0.91) and specificity of 0.54 (95% CI 0.46 to 0.62) (cut-off values of around 110 mm, from 110 to 112.5 mm; 13 studies, 1489 participants). Summary estimates for detection of varices of any size showed sensitivity of 0.93 (95% CI 0.83 to 0.97) and specificity of 0.84 (95% CI 0.75 to 0.91) in 17 studies, and 2637 participants had a cut-off value for platelet count-to-spleen length ratio of 909 (n/mm)/mm. We found no effect of predefined sources of heterogeneity. An overall indirect comparison of the HSROCs of the three index tests showed that platelet count-to-spleen length ratio was the most accurate index test when compared with platelet count (P < 0.001) and spleen length (P < 0.001). Diagnosis of varices at high risk of bleeding. Platelet count showed sensitivity of 0.80 (95% CI 0.73 to 0.85) and specificity of 0.68 (95% CI 0.57 to 0.77) (cut-off value of around 150,000/mm from 140,000 to 160,000/mm; seven studies, 1671 participants). For spleen length, we obtained only a summary ROC curve as we found no common cut-off between studies (six studies, 883 participants). Platelet count-to-spleen length ratio showed sensitivity of 0.85 (95% CI 0.72 to 0.93) and specificity of 0.66 (95% CI 0.52 to 0.77) (cut-off value of around 909 (n/mm)/mm; from 897 to 921 (n/mm)/mm; seven studies, 642 participants). An overall indirect comparison of the HSROCs of the three index tests showed that platelet count-to-spleen length ratio was the most accurate index test when compared with platelet count (P = 0.003) and spleen length (P < 0.001). DIagnosis of varices of any size in children. We found four studies including 277 children with different liver diseases and or portal vein thrombosis. Platelet count showed sensitivity of 0.71 (95% CI 0.60 to 0.80) and specificity of 0.83 (95% CI 0.70 to 0.91) (cut-off value of around 115,000/mm; four studies, 277 participants). Platelet count-to-spleen length z-score ratio showed sensitivity of 0.74 (95% CI 0.65 to 0.81) and specificity of 0.64 (95% CI 0.36 to 0.84) (cut-off value of 25; two studies, 197 participants).
AUTHORS' CONCLUSIONS: Platelet count-to-spleen length ratio could be used to stratify the risk of oesophageal varices. This test can be used as a triage test before endoscopy, thus ruling out adults without varices. In the case of a ratio > 909 (n/mm)/mm, the presence of oesophageal varices of any size can be excluded and only 7% of adults with varices of any size would be missed, allowing investigators to spare the number of oesophago-gastro-duodenoscopy examinations. This test is not accurate enough for identification of oesophageal varices at high risk of bleeding that require primary prophylaxis. Future studies should assess the diagnostic accuracy of this test in specific subgroups of patients, as well as its ability to predict variceal bleeding. New non-invasive tests should be examined.
当前指南建议在肝硬化诊断时通过食管胃十二指肠镜检查对食管静脉曲张患者进行筛查。这要求患者反复接受令人不适的侵入性检查及其伴随风险,尽管这些患者中有一半在肝硬化初诊10年后并无可识别的食管静脉曲张。血小板计数、脾脏长度以及血小板计数与脾脏长度之比是非侵入性检查,被提议作为食管静脉曲张诊断的分诊检查。
主要目的确定血小板计数、脾脏长度以及血小板计数与脾脏长度之比在诊断患有慢性肝病或门静脉血栓形成的儿童或成人患者(无论病因如何)中任何大小食管静脉曲张时的诊断准确性。研究这些非侵入性检查作为食管胃十二指肠镜检查的分诊或替代检查的准确性。次要目的比较这些相同检查在诊断患有慢性肝病或门静脉血栓形成的儿童或成人患者(无论病因如何)中高危食管静脉曲张时的诊断准确性。我们旨在对三项指标检查进行两两比较,同时考虑预定义的临界值。我们研究了异质性来源。
Cochrane肝胆组对照试验注册库、Cochrane肝胆组诊断试验准确性研究注册库、Cochrane图书馆、MEDLINE(OvidSP)、Embase(OvidSP)以及科学引文索引扩展版(Web of Science)(2016年6月14日)。我们未设语言或文献类型限制。
评估血小板计数、脾脏长度以及血小板计数与脾脏长度之比以食管胃十二指肠镜检查作为参考标准诊断患有慢性肝病或门静脉血栓形成的任何年龄儿童或成人患者(无静脉曲张出血)中食管静脉曲张的诊断准确性的研究。
采用Cochrane诊断试验准确性评价手册中概述的标准Cochrane方法。
我们纳入了71项研究,其中67项仅纳入成人,4项仅纳入儿童。所有纳入研究均为横断面研究,且在三级医疗中心进行。8项研究以摘要或信函形式报告了研究结果。我们认为除一项纳入研究外,其他所有研究均存在高偏倚风险。我们对三项指标检查临界值的定义存在重大担忧;大多数纳入研究事后得出最佳临界值,因此高估了准确性;16项研究旨在验证血小板计数与脾脏长度之比909(n/mm/mm)的临界值。6项研究的参与者招募不连续,31项研究情况不明。34项研究连续评估了参与者招募情况。11项研究将部分纳入的参与者排除在分析之外,仅1项研究中,指标检查与参考标准之间的时间间隔超过3个月。任何大小静脉曲张的诊断。血小板计数的敏感性为0.71(95%置信区间(CI)0.63至0.77),特异性为0.80(95%CI 0.69至0.88)(临界值约为150,000/mm,范围为140,000至150,000/mm;10项研究,2054名参与者)。在检查潜在的异质性来源时,我们发现所有预定义因素中,只有病因有影响:与纳入混合病因参与者的研究相比,纳入丙型肝炎参与者的研究报告了不同结果(P = 0.036)。脾脏长度的敏感性为0.85(95%CI 0.75至0.91),特异性为0.54(95%CI 0.46至0.62)(临界值约为110 mm,范围为110至112.5 mm;13项研究,1489名参与者)。17项研究中,检测任何大小静脉曲张的汇总估计敏感性为0.93(95%CI 0.83至0.97),特异性为0.84(95%CI 0.75至0.91),2637名参与者的血小板计数与脾脏长度之比临界值为909(n/mm)/mm。我们未发现预定义异质性来源的影响。三项指标检查的HSROC总体间接比较显示血小板计数与脾脏长度之比与血小板计数(P < 0.001)和脾脏长度(P < 0.001)相比是最准确的指标检查。出血高危静脉曲张的诊断。血小板计数的敏感性为0.80(95%CI 0.73至0.85),特异性为0.68(95%CI 0.57至0.77)(临界值约为150,000/mm,范围为140,000至160,000/mm;7项研究,1671名参与者)。对于脾脏长度,由于我们在各研究中未发现共同临界值,因此仅获得了汇总ROC曲线(6项研究,883名参与者)。血小板计数与脾脏长度之比的敏感性为0.85(95%CI 0.72至0.93),特异性为0.66(95%CI 0.52至0.77)(临界值约为909(n/mm)/mm;范围为897至921(n/mm)/mm;7项研究,642名参与者)。三项指标检查的HSROC总体间接比较显示血小板计数与脾脏长度之比与血小板计数(P = 0.003)和脾脏长度(P < 0.001)相比是最准确的指标检查。儿童任何大小静脉曲张的诊断。我们发现4项研究纳入了277名患有不同肝病和/或门静脉血栓形成的儿童。血小板计数的敏感性为0.71(95%CI 0.60至0.80),特异性为0.83(95%CI 从0.70至0.91)(临界值约为115,000/mm;4项研究,277名参与者)。血小板计数与脾脏长度z评分之比的敏感性为0.74(95%CI 0.65至0.81),特异性为0.64(95%CI 0.36至0.84)(临界值为25;2项研究,197名参与者)。
血小板计数与脾脏长度之比可用于对食管静脉曲张风险进行分层。该检查可在内镜检查前用作分诊检查,从而排除无静脉曲张的成人。在比值>909(n/mm)/mm的情况下,可排除任何大小食管静脉曲张的存在,仅7%的任何大小静脉曲张成人会被漏诊,从而使研究人员能够减少食管胃十二指肠镜检查的次数。该检查对于识别需要一级预防的出血高危食管静脉曲张不够准确。未来研究应评估该检查在特定患者亚组中的诊断准确性及其预测静脉曲张出血的能力。应研究新的非侵入性检查。